AMANDA BARRETT: Open Payments
NPI 1144349648 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 18 payments from 13 companies in 2025. Trend: 2023 $95 · 2024 $199 · 2025 $373
Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $71 |
| ABBVIE INC. | 2 | $50 |
| PFIZER INC. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Inspire Medical Systems, Inc. | 2 | $32 |
| Astellas Pharma US Inc | 1 | $24 |
| Dexcom, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Boston Scientific Corporation | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: Ozempic, REXULTI, PREVNAR 20, UBRELVY, INSPIRE, Veozah, Dexcom G6 Transmitter, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
